FMR1 reactivation in response to 5-azadC was also verified in vivo in (1) FXS-iPSCs that were injected into immunocompromised mice and (2) FXS-iPSC-derived NPCs transplanted into mouse brains. The gene discussed is FMR1; the disease is fragile X syndrome.